Neuropathy is a common, often debilitating complication of cancer and its treatment.
Effective management of this disorder depends on early diagnosis and an understanding of …

Neuronal DNA repair remains one of the most exciting areas for investigation, particularly as
a means to compare the DNA repair response in mitotic (cancer) vs. post-mitotic (neuronal) …

Purpose The purpose of this study was to evaluate possible risk factors for falls in a group of
patients with chemotherapy-induced peripheral neuropathy (CIPN). Methods This …

Background: A substantial portion of the 1.3 million persons diagnosed annually with cancer
receive neurotoxic chemotherapy that may produce distressful symptoms and changes in …

Purpose: In the present study, we aimed to investigate the effects of chemotherapy-induced
peripheral neurotoxicity (cipn) on psychological distress and sleep quality in cancer …

Advances in supportive care have increased the likelihood that previously less common
adverse effects of chemotherapy will be more evident. The incidence of chemotherapy …

Neuropathic pain (NP) remains difficult to control for a significant number of patients with
cancer. Chemotherapy-induced peripheral neuropathy (CIPN) has been postulated as an …

Chemotherapy‐induced peripheral neuropathy (CIPN) results from damage to or
dysfunction of the peripheral nerves. The development of CIPN is anticipated for the majority …

Cisplatin, paclitaxel and bortezomib belong to some of the most effective families of
chemotherapy drugs for solid and haematological cancers. Epothilones represent a new …

Objective: Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of
cancer treatment. There is no proven pharmacological application to prevent CIPN. This …